<!DOCTYPE html>
<!--[if (gt IE 9)|!(IE)]> <!--> <html lang="en" class="no-js has-comments blog-news section-"  itemscope xmlns:og="//opengraphprotocol.org/schema/"> <!--<![endif]-->
<!--[if IE 9]> <html lang="en" class="no-js ie9 lt-ie10 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="no-js ie8 lt-ie10 lt-ie9 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if (lt IE 8)]> <html lang="en" class="no-js lt-ie10 lt-ie9 lt-ie8 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>
		<meta name="PT" content="Blogs" />
<meta name="PST" content="Blog Post" />
<meta name="sourceApp" content="blogs" />
<meta itemprop="identifier" name="blogpostid" content="100000004003613"><meta name="author" content="Amie Tsang" />
<meta name="CLMST" content="Amie Tsang" />
<meta name="byl" content="Amie Tsang" />
<meta name="GBLC" content="DealBook">
<meta name="PUV" content="normal" />
<meta property="article:published_time" itemprop="datePublished" content="1446026857" />
<meta name="PUD" content="20151028" />
<meta name="pdate" content="20151028" />
<meta name="ptime" content="20151028060737" />
<meta name="utime" content="20151028100737" />
<meta property="article:modified_time" itemprop="dateModified" content="2015-10-28T10:07:37-04:00" />
<meta name="DISPLAYDATE" content="October 28, 2015" />
<meta name="dat" content="October 28, 2015" />
<meta itemprop="articleSection" property="article:section" content="" />
<meta name="CG" content="" />
<meta name="SCG" content="news" />
<meta name="BN" content="news" />
<meta name="robots" content="noodp">
<meta name="des" content="Art;Barclays PLC;Drugs (Pharmaceuticals);Federal Reserve System;Hedge Funds;Initial Public Offerings;Interest Rates;International Business Machines Corporation;Libor (London Interbank Offered Rate);Mergers, Acquisitions and Divestitures;Soros, George;Valeant Pharmaceuticals International Inc;Whistle-Blowers">
<meta name="org" content="Anheuser-Busch InBev NV;Cablevision Systems Corporation;Credit Suisse Group AG;Goldman Sachs Group Inc;KKR &amp; Co LP;Molson Coors Brewing Company;Rite Aid Corporation;Securities and Exchange Commission;St. Joe Company;Starwood Hotels &amp; Resorts Worldwide Inc;Theranos Inc;Walgreen Co.">
<meta name="ticker" content="Anheuser-Busch InBev NV|BUD|NYSE;Cablevision Systems Corporation|CVC|NYSE;Credit Suisse Group AG|CS|NYSE;Goldman Sachs Group Inc|GS|NYSE;Molson Coors Brewing Company|TAP|NYSE;Rite Aid Corporation|RAD|NYSE;St. Joe Company|JOE|NYSE;Starwood Hotels & Resorts Worldwide Inc|HOT|NYSE;Walgreen Co.|WBA|NASDAQ" />
<meta property="article:tag" content="Art" />
<meta property="article:tag" content="Barclays PLC" />
<meta property="article:tag" content="Drugs (Pharmaceuticals)" />
<meta property="article:tag" content="Federal Reserve System" />
<meta property="article:tag" content="Hedge Funds" />
<meta property="article:tag" content="Initial Public Offerings" />
<meta property="article:tag" content="Interest Rates" />
<meta property="article:tag" content="International Business Machines Corporation" />
<meta property="article:tag" content="Libor (London Interbank Offered Rate)" />
<meta property="article:tag" content="Mergers Acquisitions and Divestitures" />
<meta property="article:tag" content="Soros George" />
<meta property="article:tag" content="Valeant Pharmaceuticals International Inc" />
<meta property="article:tag" content="Whistle-Blowers" />
<meta property="article:tag" content="Anheuser-Busch InBev NV" />
<meta property="article:tag" content="Cablevision Systems Corporation" />
<meta property="article:tag" content="Credit Suisse Group AG" />
<meta property="article:tag" content="Goldman Sachs Group Inc" />
<meta property="article:tag" content="KKR &amp; Co LP" />
<meta property="article:tag" content="Molson Coors Brewing Company" />
<meta property="article:tag" content="Rite Aid Corporation" />
<meta property="article:tag" content="Securities and Exchange Commission" />
<meta property="article:tag" content="St. Joe Company" />
<meta property="article:tag" content="Starwood Hotels &amp; Resorts Worldwide Inc" />
<meta property="article:tag" content="Theranos Inc" />
<meta property="article:tag" content="Walgreen Co." />
<meta property="article:tag" content="DealBook" />
<meta name="keywords" content="Art,Barclays PLC,Drugs (Pharmaceuticals),Federal Reserve System,Hedge Funds,Initial Public Offerings,Interest Rates,International Business Machines Corporation,Libor (London Interbank Offered Rate),Mergers Acquisitions and Divestitures,Soros George,Valeant Pharmaceuticals International Inc,Whistle-Blowers,Anheuser-Busch InBev NV,Cablevision Systems Corporation,Credit Suisse Group AG,Goldman Sachs Group Inc,KKR &amp; Co LP,Molson Coors Brewing Company,Rite Aid Corporation,Securities and Exchange Commission,St. Joe Company,Starwood Hotels &amp; Resorts Worldwide Inc,Theranos Inc,Walgreen Co.,DealBook" />
<meta name="news_keywords" content="Anheuser-Busch InBev,Art,Cablevision,Credit Suisse Group,Goldman Sachs Group,Hedge fund,Interest rate,IPO,KKR,Libor,Mergers and Acquisitions,Molson Coors Brewing,Pharmaceuticals,Rite Aid,SEC,St Joe,Starwood Hotels,Theranos,Whistleblower" />
<link rel="alternate" type="application/json+oembed" href="https://www.nytimes.com/svc/oembed/json/?url=http%3A%2F%2Fnews.blogs.nytimes.com%2F2015%2F10%2F28%2Fmorning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time%2F" title="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time" />
<meta name="description" content="Walgreens to Buy Rite Aid &#124; Valeant Shows the Risk of Follow the Leader &#124; James Staley Named Chief of Barclays" />
<meta name="hdl" content="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time" />
<meta property="og:title" content="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time" />
<meta property="og:type" content="article" />
<meta property="og:url" content="//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/" />
<meta property="og:site_name" content="" />
<meta property="og:description" content="Walgreens to Buy Rite Aid &#124; Valeant Shows the Risk of Follow the Leader &#124; James Staley Named Chief of Barclays" />
<meta property="og:image" content="https://static01.nyt.com/images/blogs_v5/../icons/t_logo_2048_black.png"/>
<meta name="thumbnail_150" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta name="twitter:card" value="summary"><meta name="twitter:title" content="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time" />
<meta name="twitter:url" content="//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/" />
<meta name="twitter:description" content="Walgreens to Buy Rite Aid &#124; Valeant Shows the Risk of Follow the Leader &#124; James Staley Named Chief of Barclays" />
<meta name="twitter:image" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta itemprop="thumbnailUrl" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png" name="thumbnail" />
<link rel='prev' title='What We&#8217;re Reading' href='//news.blogs.nytimes.com/2015/10/27/what-were-reading-101/' />
<link rel='next' title='Morning Agenda: Deutsche Bank to Cut 35,000 Jobs Under New Strategy' href='//news.blogs.nytimes.com/2015/10/29/morning-agenda-deutsche-bank-to-cut-35000-jobs-under-new-strategy/' />
<link rel='canonical' href='//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/' />
<link rel='shortlink' href='//nyti.ms/1LBwkAO' />
<link rel='https://github.com/WP-API/WP-API' href='//news.blogs.nytimes.com/json' />
<meta name="adxPage" content="blog.nytimes.com/news/post" />
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="//news.blogs.nytimes.com/feed/" />
<meta property="article:collection" content="https://static01.nyt.com/services/json/sectionfronts/index.jsonp" />
<link rel="alternate" href="//mobile.nytimes.com/blogs/news/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/" />
<meta name="dfp-ad-unit-path" content="news" />			<title>Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time - The New York Times</title>
            <!--[if (gt IE 9)|!(IE)]> <!-->
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles.css" />
<!--<![endif]-->
<!--[if lte IE 9]>
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-ie.css" />
<![endif]-->
<link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/news.css" />
<link rel="stylesheet" type="text/css" media="print" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-print.css" />
<script>
var NYT = NYT || {}, NYTD = NYTD || {};
</script>
                        	<script src="https://int.nyt.com/assets/blogs/latest/js/blogs/layout.js"></script>
	<script type="text/javascript">var googletag=googletag||{};googletag.cmd=googletag.cmd||[],function(){var t=document.createElement("script");t.async=!0,t.type="text/javascript";var e="https:"==document.location.protocol;t.src=(e?"https:":"http:")+"//www.googletagservices.com/tag/js/gpt.js";var o=document.getElementsByTagName("script")[0];if (!/NYT-T=out/.test(document.cookie)) {o.parentNode.insertBefore(t,o)}}();</script>
<script id="magnum-feature-flags" type="application/json">["limitFabrikSave","facebookOauthButton","videoVHSCover","videoVHSShareTools","videoVHSEmbeddedOnly","removeInternationalEdition","piiBlockDFP","indexAsHeaderBidder","caslOpt"]</script>
<script>
var require = {
    baseUrl: 'https://int.nyt.com/assets/',
    waitSeconds: 20,
    paths: {
        'foundation': 'blogs/latest/js/foundation',
        'shared': 'blogs/latest/js/shared',
        'blogs': 'blogs/latest/js/blogs',
        'auth/mtr': 'https://static01.nyt.com/js/mtr',
        'auth/growl': 'https://static01.nyt.com/js/auth/growl/default',
        'vhs': 'https://static01.nyt.com/video/vhs/build/vhs-2.x.min'
    }
};
</script>
<!--[if (gte IE 9)|!(IE)]> <!-->
<script data-main="foundation/main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script>
require.map = { '*': { 'foundation/main': 'foundation/legacy_main' } };
</script>
<script data-main="foundation/legacy_main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<![endif]-->
<script>
require(['foundation/main'], function () {
    require(['auth/mtr']);
});
</script>
<!--esi
<script id="user-info-data" type="application/json">
<esi:include src="/svc/web-products/userinfo-v3.json" />
</script>
-->
    	</head><body class="single single-post postid-3530 blog-universal nyt-blog-news full-width-headline" id="" data-env="production" data-region="ewr1">
	<div id="shell" class="shell">
			<header id="masthead" class="masthead masthead-theme-standard" role="banner">
    <div class="container">
        <div class="quick-navigation button-group">
            <button class="button sections-button"><i class="icon sprite-icon"></i><span class="button-text">Sections</span></button>
            <button class="button home-button" data-href="https://www.nytimes.com/" title="Go to the home page to see the latest top stories."><i class="icon sprite-icon"></i>
                <span class="button-text">Home</span>
            </button>
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <a class="button skip-button skip-to-content visually-hidden focusable" href="#main">Skip to content</a>
                                </div><!-- close button-group -->
        <div class="branding">
            <h2 class="branding-heading">
                <a id="branding-heading-link" href="https://www.nytimes.com/">
                    <span class="visually-hidden">The New York Times</span>
                </a>
            </h2>
            <script>window.magnum.writeLogo('small', 'https://int.nyt.com/assets/blogs/latest/images/foundation/logos/', '', 'masthead-theme-standard', 'standard', 'branding-heading-link', 'blogs');</script>
        </div><!-- close branding -->
        <div class="story-meta">
    <h6 class="kicker">
        <span class="kicker-label">
			            <a href="//news.blogs.nytimes.com">
                News            </a>
			        </span>

                <span class="pipe">|</span>
        Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time        
    </h6>
</div><!-- close story-meta -->


        <div class="user-tools">
            <div id="Bar1" class="ad bar1-ad nocontent robots-nocontent"></div>
            <div id="sharetools-masthead" class="sharetools theme-classic"
	 data-shares="email,facebook,twitter,show-all|More"
	 data-url="//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/"
	 data-title="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time"
	 data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
	data-publish-date="October 28, 2015 6:07 am">
<div class="ad sharetools-inline-article-ad hidden"></div>
</div><!-- close shareTools -->
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <div class="user-tools-button-group button-group">
                <button class="button subscribe-button hidden" data-href="https://www.nytimes.com/subscriptions/Multiproduct/lp3004.html?campaignId=4XUYF">Subscribe Now</button>
                <button class="button login-button login-modal-trigger hidden">Log In</button>
                <button class="button comments-button  button-masthead" data-skip-to-para-id="">
</button>
                                <button class="button notifications-button hidden"><i class="icon sprite-icon"></i><span class="button-text">0</span></button>
                <button class="button user-settings-button"><i class="icon sprite-icon"></i><span class="button-text">Settings</span></button>
            </div><!-- close user-tools-button-group -->
        </div><!-- close user-tools -->
    </div><!-- close container -->
    <div class="search-flyout-panel flyout-panel">
    <button class="button close-button" type="button"><i class="icon"></i><span class="visually-hidden">Close search</span></button>
    <nav class="search-form-control form-control layout-horizontal">
    <h2 class="visually-hidden">Site Search Navigation</h2>
    <form class="search-form" role="search">
        <div class="control">
            <div class="label-container visually-hidden">
                                <label for="search-input">Search NYTimes.com</label>
                            </div>
            <div class="field-container">
                                <input id="search-input" name="search-input" type="text" class="search-input text" autocomplete="off" placeholder="Search NYTimes.com" />
                
                <button type="button" class="button clear-button" tabindex="-1" aria-describedby="clear-search-input"><i class="icon"></i><span id="clear-search-input" class="visually-hidden">Clear this text input</span></button>
                <div class="auto-suggest" style="display: none;">
                    <ol></ol>
                </div>
                <button class="button submit-button" type="submit">Go</button>
            </div>
        </div><!-- close control -->
    </form>
</nav>


</div><!-- close flyout-panel -->
    <div id="notification-modals" class="notification-modals"></div>
</header>
					<nav id="ribbon" class="ribbon ribbon-start nocontent robots-nocontent" aria-hidden="true">
    <div class="nocontent robots-nocontent">
        <ol class="ribbon-menu">
            <li class="collection ribbon-loader">
                <div class="loader "><span class="visually-hidden">Loading...</span></div>
            </li>
        </ol>
        <div class="ribbon-navigation-container">
            <nav class="ribbon-navigation next">
                <span class="visually-hidden">See next articles</span>
                <div class="arrow arrow-right">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
            <nav class="ribbon-navigation previous">
                <span class="visually-hidden">See previous articles</span>
                <div class="arrow arrow-left">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
        </div>
    </div><!-- close nocontent -->
</nav>
						<nav id="navigation" class="navigation">
    <h2 class="visually-hidden">Site Navigation</h2>
</nav><!-- close navigation -->

<nav id="mobile-navigation" class="mobile-navigation hidden">
    <h2 class="visually-hidden">Site Mobile Navigation</h2>
</nav><!-- close mobile-navigation -->

    <div id="navigation-edge" class="navigation-edge"></div>
				<main id="main" class="main" role="main">
				<div id="TopAd" class="ad top-ad"></div>
				<div id="mobilebanner" class="ad mobilebanner"></div>
								<div id="story" class="story theme-main">
		<div id="news" class="spanAC blog">
				<div class="postHeader story-header">
	<div class="story-meta">
						<h1 class="entry-title story-heading">Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time</h1>
		<div class="story-meta-footer">
			<address class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
				By Amie Tsang			</address>
			<!-- date published --><time class="dateline " datetime="2015-10-28T10:07:37+00:00" itemprop="datePublished">October 28, 2015</time>
			<!-- date updated --><span class="visually-hidden updated">October 28, 2015</span>			<div class="inside-story"></div><!-- Although this is empty, it is required for layout parity with NYT5 -->
		</div>
	</div>
</div>
<div class="a-column" id="a-col">
	<div id="content" class="hfeed">
			<article class="post-3530 post type-post status-publish hentry category-dealbook tag-anheuser-busch-inbev-nv tag-art tag-barclays-plc tag-cablevision-systems-corporation tag-credit-suisse-group-ag tag-drugs-pharmaceuticals tag-federal-reserve-system tag-goldman-sachs-group-inc tag-hedge-funds tag-initial-public-offerings tag-interest-rates tag-international-business-machines-corporation tag-kkr-co-lp tag-libor-london-interbank-offered-rate tag-mergers-acquisitions-and-divestitures tag-molson-coors-brewing-company tag-rite-aid-corporation tag-securities-and-exchange-commission tag-soros-george tag-st-joe-company tag-starwood-hotels-resorts-worldwide-inc tag-theranos-inc tag-valeant-pharmaceuticals-international-inc tag-walgreen-co tag-whistle-blowers des-art des-barclays-plc des-drugs-pharmaceuticals des-federal-reserve-system des-hedge-funds des-initial-public-offerings des-interest-rates des-international-business-machines-corporation des-libor-london-interbank-offered-rate des-mergers-acquisitions-and-divestitures des-soros-george des-valeant-pharmaceuticals-international-inc des-whistle-blowers org-anheuser-busch-inbev-nv org-cablevision-systems-corporation org-credit-suisse-group-ag org-goldman-sachs-group-inc org-kkr-co-lp org-molson-coors-brewing-company org-rite-aid-corporation org-securities-and-exchange-commission org-st-joe-company org-starwood-hotels-resorts-worldwide-inc org-theranos-inc org-walgreen-co news_keywords-anheuser-busch-inbev news_keywords-art news_keywords-cablevision news_keywords-credit-suisse-group news_keywords-goldman-sachs-group news_keywords-hedge-fund news_keywords-interest-rate news_keywords-ipo news_keywords-kkr news_keywords-libor news_keywords-mergers-and-acquisitions news_keywords-molson-coors-brewing news_keywords-pharmaceuticals news_keywords-rite-aid news_keywords-sec news_keywords-st-joe news_keywords-starwood-hotels news_keywords-theranos news_keywords-whistleblower" id="post-3530">
                        <div class="visually-hidden">
                <span itemprop="headline" class="entry-title">Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time</span>
                <span class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
                    By Amie Tsang                </span>
                <!-- date published --><time class="dateline " datetime="2015-10-28T10:07:37+00:00" itemprop="datePublished">October 28, 2015 6:07 am</time>
			<!-- date updated --><span class="visually-hidden updated">October 28, 2015 6:07 am</span>            </div>
			<div class="entry-content">
			<div id="sharetools-story" class="sharetools theme-classic sharetools-story" data-shares="email|Email,facebook|Share,twitter|Tweet,save|Save,show-all|More,ad" data-url="//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/" data-title="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time" data-description="Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays">
				<div class="ad sharetools-inline-article-ad"></div>
				<div id="MiddleLeft" class="ad middle-left-ad nocontent robots-nocontent"></div>
				</div><div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>ANHEUSER-BUSCH INBEV AND SABMILLER GET MORE TIME</strong> <span class="divider"> | </span></span> SABMiller and Anheuser-Busch InBev have <b>another week</b> to try to complete a deal after British regulators extended the deadline for their talks,</p>
<p class="story-body-text" itemprop="articleBody"><a href="//www.nytimes.com/2015/10/29/business/dealbook/anheuser-busch-inbev-sabmiller-beer-deal-talks.html?ref=business">Chad Bray reports in DealBook.</a></p>
<p class="story-body-text" itemprop="articleBody">Anheuser-Busch InBev, the worldâs largest brewer, reached an agreement in principle on Oct. 13 to acquire SABMiller, its closest rival, for about $104 billion.</p>
<p class="story-body-text" itemprop="articleBody">They were facing a deadline on Wednesday for Anheuser-Busch InBev to make a formal offer under British takeover rules or not make another approach for up to six months. The deadline has been <b>extended to Nov. 4</b>.</p>
<p class="story-body-text" itemprop="articleBody">The companies said Anheuser-Busch InBev had completed its âdue diligence reviewâ and confirmed that âfacilities which will allow AB InBev to provide <b>certain funds in support of the cash components</b> of the possible offer have been negotiated and can be executed at short notice.â</p>
<p class="story-body-text" itemprop="articleBody">The new deadline gives the companies more time to complete their negotiations and potentially create a behemoth in the beer industry with annual revenue of about $64 billion.</p>
<p class="story-body-text" itemprop="articleBody">The merger, if it were to occur, would probably <b>face regulatory scrutiny</b>, and the brewers may be forced to sell off some assets where they overlap, including the United States.</p>
<p class="story-body-text" itemprop="articleBody"><a href="//www.ft.com/intl/cms/s/0/7431447e-7d15-11e5-a1fe-567b37f80b64.html#axzz3pe7uqjAl">The Financial Times </a> reports that<br />
Anheuser-Busch InBev has hired bankers to explore a sale of assets in the United States. Lazard and Barclays have been appointed to <b>sell SABMillerâs 58 percent stake</b> in a joint venture with Molson Coors for as much as $10 billion, according to people with knowledge of the matter. </p>
<p class="story-body-text" itemprop="articleBody">The deal would potentially bring some of the worldâs most popular beers, including Budweiser, Stella Artois, Grolsch and Peroni, under one roof.</p>
<p class="story-body-text" itemprop="articleBody">It would also give Anheuser-Busch InBev more exposure to faster-growing emerging markets, particularly in Africa and Latin America.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>WALGREENS TO BUY RITE AID</strong> <span class="divider"> | </span></span> Walgreens Boots Alliance said it would buy Rite Aid for more than <b>$9.4 billion in cash</b>,<br />
<a href="//www.nytimes.com/2015/10/28/business/dealbook/walgreens-rite-aid-deal.html?ref=dealbook">Michael J. de la Merced and Hiroko Tabuchi report in DealBook.</a> The deal will give the two biggest drugstore chains in the United States more influence with drug makers and pharmacy benefit managers and comes as companies throughout the industry are consolidating in the face of changes to the Affordable Care Act. </p>
<p class="story-body-text" itemprop="articleBody">Rite Aid shareholders will receive $9 a share â a <b>premium of 48 percent</b> to its closing stock price on Monday. The deal gives Rite Aid a total enterprise value of $17.2 billion. </p>
<p class="story-body-text" itemprop="articleBody">Walgreens would get an <b>additional 4,600 stores</b> in 31 states, adding to its roughly 8,200 locations across the country, Puerto Rico and the Virgin Islands.</p>
<p class="story-body-text" itemprop="articleBody">The combination may well draw <b>scrutiny from regulators</b> worried about the retail pharmacy market being boiled down to just a few big chains. They will probably focus on regions where there is an overlap in their business. </p>
<p class="story-body-text" itemprop="articleBody">CVS, the biggest drugstore chain by market cap, has grown to 7,800 stores, buying up pharmacies along the way. </p>
<p class="story-body-text" itemprop="articleBody">Walgreens Boots Alliance has made no secret of its <b>desire to expand</b> through acquisitions and  has hinted that Rite Aid would be a target. </p>
<p class="story-body-text" itemprop="articleBody">Before Walgreens bought the European chain Alliance Boots, it had already acquired Duane Reade, USA Drugs and Kerr Drug. Rite Aid had fallen to be the third largest pharmacy chain after <b>years of steep losses</b>.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>VALEANT SHOWS THE RISK OF FOLLOW THE LEADER</strong> <span class="divider"> | </span></span> The recent plunge in Valeant shares has revealed the dangerous tendency for hedge funds to plunge in and out of stocks <b>in a herdlike fashion</b>, </p>
<p class="story-body-text" itemprop="articleBody"><a href="//www.nytimes.com/2015/10/28/business/dealbook/valeant-stock-plunge-shows-risk-of-following-the-leader.html?ref=dealbook">Steven Davidoff Solomon writes in the Deal Professor column.</a></p>
<p class="story-body-text" itemprop="articleBody">The hedge funds invested in Valeant, which includes names like William A. Ackman and John Paulson, took a hit. ValueAct Capital has been <b>enormously invested in Valeant</b>. Although it sold 4.2 million shares a month ago, the fund still owns 4.4 percent of the company and had made a return of more than 2,100 percent as of September. </p>
<p class="story-body-text" itemprop="articleBody"><b>Herd investing</b> is common among hedge funds. Goldman Sachs runs an index of the 50 stocks most widely held by hedge funds. At the top of the list is Allergan â there are 67 hedge funds that count it as one of their top 10 holdings. It is followed by Apple and Facebook. Valeant makes No. 10 with 22 percent of its shares held by hedge funds. </p>
<p class="story-body-text" itemprop="articleBody">âLooking at the list, one has to shake oneâs head,â Mr. Solomon writes. âAfter all, I, too, can do this <b>trick of investing</b> in big and well-known tech and pharmaceutical companies, for much less than the fee of 20 percent of the profits that hedge funds charge.â</p>
<p class="story-body-text" itemprop="articleBody">Mr. Solomon wonders whether many hedge funds are simply playing follow the leader. With thousands of stocks, hedge funds seem to be concentrating their bets on larger caps and certain industries, like tech and pharmaceuticals. This <b>may work in a rising market</b>, but a decline would be painful. </p>
<p class="story-body-text" itemprop="articleBody">If hedge funds are <b>all about alpha</b> â finding investments that are undervalued and that can outperform the broader market â then migrating to smaller stocks might bear more fruit and make their research the most useful.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>ON THE AGENDA</strong> <span class="divider"> | </span></span> <b>Volkswagenâs</b> conference call on its third-quarter results starts at 7:30 a.m. <b>Anthemâs</b> earnings call starts at 8:30 a.m. <b> PayPal</b> will discuss its latest earnings in a conference call at 5 p.m. <b>Michael L. Corbat</b>, chief executive of Citigroup, will speak at the Economic Club of Washington at midday. </p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>JAMES STALEY NAMED CHIEF OF BARCLAYS</strong> <span class="divider"> | </span></span> Barclays named James E. Staley, a former senior investment banker at JPMorgan Chase and hedge fund executive, as its new chief executive,</p>
<p class="story-body-text" itemprop="articleBody"><a HREF="//www.nytimes.com/2015/10/29/business/dealbook/james-staley-barclays-chief-jpmorgan.html">Chad Bray reports in DealBook.</a></p>
<p class="story-body-text" itemprop="articleBody">Barclays is looking to speed up its turnaround and the hiring is <b>a sharp reversal for the British bank</b>, after it aggressively reshaped its culture and shrank its investment bank. </p>
<p class="story-body-text" itemprop="articleBody">It admitted three years ago that its traders had conspired to manipulate a global benchmark interest rate and the <b>ensuing scandal</b> cost Robert E. Diamond Jr. his job as chief executive after he had pushed to make the British lender a Wall Street powerhouse.  </p>
<p class="story-body-text" itemprop="articleBody">Mr. Diamond was replaced by Antony Jenkins, a retail banker who was the polar opposite of his hard-charging predecessor. He was praised for trying to change the bankâs culture, but was <b>ousted this summer</b> when directors lost confidence in him. </p>
<p class="story-body-text" itemprop="articleBody">Mr. Staley, 58, rose from being a junior banker to leading JPMorganâs investment bank and was regarded as a potential successor to Jamie Dimon. He left in 2013 to join BlueMountain Capital Management, a hedge fund.<br />
<b>He starts on December 1</b>. </p>
<p class="story-body-text" itemprop="articleBody">âIn Jes Staley we believe we have an executive with the appropriate leadership talent and wide-ranging experience to deliver shareholder value and to take the group forward strategically,â John McFarlane, the Barclays chairman, said. âIn particular, <b>he understands corporate and investment banking well</b>, the re-positioning of which is one of our major priorities.â</p>
<p class="story-body-text" itemprop="articleBody">The hiring of Mr. Staley came as Barclaysâ closest <b>investment banking rivals</b> in Europe have replaced their top executives in an effort to reshape their organizations and improve returns as regulatory scrutiny is getting stricter. </p>
<p class="story-body-text" itemprop="articleBody">Like several of his investment banking rivals, Mr. Staley has experience in asset management and private banking, areas that many <b>European banks are turning to</b> as they shed riskier business lines.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong></strong> <span class="divider"> | </span></span> <em>Contact <a href="mailto:amie.tsang@nytimes.com">amie.tsang@nytimes.com</a></em></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//dealbook.blogs.nytimes.com/category/mergers-acquisitions/">Mergers &#038; Acquisitions &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Chinese Firms Vie to Buy Starwood Hotels</strong> <span class="divider"> | </span></span> At least three big Chinese companies are competing to win Beijingâs approval to bid for Starwood Hotels &#038; Resorts Worldwide, The Wall Street Journal reports, citing people with knowledge of the discussions. Their proposals set the stage for what could be the largest-ever Chinese takeover of a company in the United States.<br /><span class="kicker"><a href="//www.wsj.com/articles/chinese-firms-vie-to-buy-starwood-hotels-1445968609?mod=asia_home"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="National Australia Bank to Sell 80% of Life Insurance Business to Nippon Life" src="https://static01.nyt.com/images/2015/10/29/business/29db-nabinsurance/29db-nabinsurance-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>National Australia Bank to Sell 80% of Life Insurance Business to Nippon Life</strong> <span class="divider"> | </span></span> The $1.7 billion deal is being made as Japanese insurers acquire overseas firms as their domestic customers age.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/29/business/dealbook/national-australia-bank-nab-nippon-life-insurance-deal.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Consortium Plans to Buy 30% Stake in Cablevision for $1 Billion</strong> <span class="divider"> | </span></span> The deal led by the Canada Pension Plan Investment Board and funds advised by BC Partners would be part of a takeover by Altice, a European telecommunications company.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/cablevision-altice-consortium.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>IBM Nearing Acquisition of Weather Companyâs Assets</strong> <span class="divider"> | </span></span> The deal, which would be valued at more than $2 billion, could be announced as early as Wednesday, The Wall Street Journal reports, citing  people familiar with the situation.<br /><span class="kicker"><a href="//www.wsj.com/articles/ibm-nearing-acquisition-of-weather-co-s-digital-and-data-assets-1445984616?mod=pls_whats_news_us_business_f"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/b/banks_and_banking/index.html">INVESTMENT BANKING &#187;</a></h6>
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Top Defendant Testifies in First Libor Criminal Trial in U.S. " src="https://static01.nyt.com/images/2015/10/28/business/28DB-LIBOR/28DB-LIBOR-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Top Defendant Testifies in First Libor Criminal Trial in U.S. </strong> <span class="divider"> | </span></span> Anthony Allen, on trial for manipulating Libor, said that when he appeared to agree to tradersâ demands at the bank where he worked at the time, he was actually trying to brush them off.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/top-defendant-testifies-in-first-libor-criminal-trial-in-us.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Credit Suisse Hires Five Health Care Bankers</strong> <span class="divider"> | </span></span> Punit Mehta, who was global head of life sciences at Barclays, and four other bankers will join the Swiss bank.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/credit-suisse-hires-five-health-care-bankers.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Goldman Sachs to Spin Out Mobile Phone Projects</strong> <span class="divider"> | </span></span> Goldman Sachs said it is spinning out the mobile phone software it developed in-house into a new venture,  managed and majority-owned by Synchronoss Technologies, a publicly traded software firm.<br /><span class="kicker"><a href="//www.wsj.com/articles/goldman-sachs-to-spin-out-mobile-phone-software-projects-into-separate-venture-1445981960?mod=asia_home"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/p/private_equity/index.html">PRIVATE EQUITY &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Kohlberg Kravis Posts Big Loss as Private Equity Struggles</strong> <span class="divider"> | </span></span> The firm also announced plans to buy back $500 million of its shares and make fixed distributions to shareholders.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/kohlberg-kravis-posts-steep-loss-for-quarter.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/h/hedge_funds/index.html">HEDGE FUNDS &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>St. Joe Company Settles With S.E.C. on Overvaluing Land Holdings</strong> <span class="divider"> | </span></span> St. Joe, a real estate developer, will pay $2.75 million over accusations of improper accounting, a claim that David Einhorn, an activist investor, had raised for years.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/st-joe-company-settles-with-sec-on-overvaluing-land-holdings.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/i/initial_public_offerings/index.html">I.P.O./OFFERINGS &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>French Music Streaming Service Postpones I.P.O.</strong> <span class="divider"> | </span></span> The service, Deezer, blamed tough market conditions and weak investor appetite as it became the latest company to postpone its planned public listing.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/deezer-french-music-streaming-service-postpones-ipo.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>ABN Amro I.P.O. Will Go Ahead, Dutch Government Says</strong> <span class="divider"> | </span></span> The state is trying to recoup tens of billions of dollars it spent to rescue the lender in 2008, and it could proceed with an offering this year.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/abn-amro-ipo.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Poste Italiane and Equiniti Fail to Excite in Market Debuts</strong> <span class="divider"> | </span></span> The lackluster starts came as the Dutch government announced plans to proceed with an initial public offering of the state-owned lender ABN Amro.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/poste-italiane-and-equiniti-fail-to-excite-in-market-debuts.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/v/venture_capital/index.html">VENTURE CAPITAL &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Online Auction House Aims to Give Big Houses Run for Money</strong> <span class="divider"> | </span></span> Paddle8, a 4-year-old start-up with big-name backers, plans to announce on Wednesday that it has raised $34 million in a new round of financing.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/online-auction-house-aims-to-give-big-houses-a-run-for-their-money.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="F.D.A. Cites Unapproved Device in Theranos Review, and Faults Handling of Complaints" src="https://static01.nyt.com/images/2015/10/28/business/28theranos-web/28theranos-web-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>F.D.A. Cites Unapproved Device in Theranos Review, and Faults Handling of Complaints</strong> <span class="divider"> | </span></span> An inspection of the blood testing company found that its tiny blood collection tubes had not been cleared by regulators. It was also found to be lax on following up on consumer complaints.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/theranos-quality-control-was-questioned-by-fda.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Breakingviews: Theranos Under Fire</strong> <span class="divider"> | </span></span> With questions raised about the blood-testing companyâs technology, its purported $9 billion valuation now looks overestimated, Richard Beales writes.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/theranos-under-fire.html">Breakingviews &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Thiel and Soros Invest in Bond Trading Start-Up</strong> <span class="divider"> | </span></span> The $27 million investment in TruMid Financial comes as the market moves toward electronic trading.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/thiel-and-soros-invest-in-bond-trading-start-up.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/c/credit_crisis/financial_regulatory_reform/index.html">LEGAL/REGULATORY &#187;</a></h6>
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Fed Seen as Unlikely to Raise Rates" src="https://static01.nyt.com/images/2015/10/28/business/28fedb-web1/28fedb-web1-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Fed Seen as Unlikely to Raise Rates</strong> <span class="divider"> | </span></span> The case for increasing the benchmark rate has weakened since the summer, as the global economy struggles and domestic growth idles. Still, some see continued delays as untenable.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/economy/fed-seen-as-unlikely-to-raise-rates-as-pressures-mount-from-both-sides.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Another View: Whistle-Blower Case Deserved a Fuller Examination</strong> <span class="divider"> | </span></span> A federal district court and an appeals court threw out Carmen Segarraâs lawsuit, and neither court offered very persuasive reasons for doing so, David Zaring writes.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/whistle-blower-case-deserved-a-fuller-examination.html">Another View &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>New York Stateâs Financial Regulator Says He Is Leaving</strong> <span class="divider"> | </span></span> Anthony J. Albanese, superintendent of the State Department of Financial Services, disputed reports that he was resigning over tensions with the governorâs office.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/nyregion/new-york-states-financial-regulator-says-he-is-leaving.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="IBM Discloses S.E.C. Investigation" src="https://static01.nyt.com/images/2015/10/27/technology/27bits-rometty/27bits-rometty-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>IBM Discloses S.E.C. Investigation</strong> <span class="divider"> | </span></span> The computing giant disclosed in a regulatory filing that accounting practices in three countries are under scrutiny.<br /><span class="kicker"><a href="//bits.blogs.nytimes.com/2015/10/27/ibm-discloses-s-e-c-investigation/">Bits Blog &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Federal Investigators Said To Examine Valeantâs Contact Lens Dealings</strong> <span class="divider"> | </span></span> The Federal Trade Commission is investigating whether Valeant has illegally cornered the market for a key component of rigid contact lenses, ProPublica reports, citing people familiar with the inquiry.<br /><span class="kicker"><a href="//www.propublica.org/article/federal-investigators-looking-at-valeant-contact-lens-dealings"> PROPUBLICA </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Is Valeant Pharmaceuticals the Next Enron?" src="https://static01.nyt.com/images/2014/11/01/opinion/nocera-circular/nocera-circular-thumbStandard-v2.png"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Is Valeant Pharmaceuticals the Next Enron?</strong> <span class="divider"> | </span></span> Accusations about Valeantâs practices and its own disclosures while under pressure cause one to wonder, Joe Nocera writes.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/27/opinion/is-valeant-pharmaceuticals-the-next-enron.html">Op-Ed Columnist &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>S.E.C. Takes Tougher Stance on Enforcement in JPMorgan Case</strong> <span class="divider"> | </span></span> Federal regulators want to restrict JPMorgan Chaseâs ability to raise funds for clients, in an effort to impose a broader range of consequences on financial firms accused of breaking the rules, The Wall Street Journal reports, citing people familiar with the matter.<br /><span class="kicker"><a href="//www.wsj.com/articles/sec-takes-tougher-stance-on-enforcement-in-j-p-morgan-case-1445986962?mod=rss_markets_main"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="House Votes Overwhelmingly to Reopen the Ex-Im Bank" src="https://static01.nyt.com/images/2015/10/28/business/28EXIM/28EXIM-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>House Votes Overwhelmingly to Reopen the Ex-Im Bank</strong> <span class="divider"> | </span></span> In a rare act of bipartisanship, representatives approved the legislation in a 313-to-118 vote that defied free-market conservatives.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/us/politics/house-votes-overwhelmingly-to-reopen-the-ex-im-bank.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>New York State Says Only 61% Passed Bar Exam in July</strong> <span class="divider"> | </span></span> Excluding those educated abroad, however, the pass rate was 79 percent, in line with the rate in many other states.<br /><span class="kicker"><a href="//www.nytimes.com/2015/10/28/business/dealbook/new-york-state-says-only-61-passed-bar-exam-in-july.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="newsletter-signup">
<p class="story-body-text" itemprop="articleBody"><a href="//dealbook.nytimes.com/dealbook-e-mail/">Sign up for the DealBook Newsletter</a>, delivered every morning and afternoon.</p>
</div>
<p class="story-body-text" itemprop="articleBody"></p>
</div>
			<footer class="entry-footer">
				
				<div id="sharetools-post-footer" class="sharetools theme-classic"
					data-shares="show-all|Share"
					data-url="//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/"
					data-title="Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time"
					data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
					>
					<div class="ad sharetools-inline-article-ad hidden"></div>
				</div>
				<div class="footer-tags">
									</div>
			</footer>
		</article>
		<section id="whats-next" class="whats-next nocontent robots-nocontent">
    <h2 class="visually-hidden">What's Next</h2>
    <div class="nocontent robots-nocontent">
        <div class="loader-container">
            <div class="loader loader-t-logo-32x32-ecedeb-ffffff"><span class="visually-hidden">Loading...</span></div>
        </div>
    </div><!-- close nocontent -->
</section>

		</div> <!-- end content -->
</div><!-- end .a-column -->
<div class="cColumn nocontent robots-nocontent">
	<aside>
			<div class="module ad" id="MiddleRight"></div>
        	</aside>
</div>		<div class="clear"></div>
	</div><!-- end blog wrap -->
	<div class="hideContent"></div>

	
<!-- Google Analytics start -->
<script type="text/javascript">
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;if (!/NYT-T=out/.test(document.cookie)) {m.parentNode.insertBefore(a,m)} })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-4406282-154',  { 'alwaysSendReferrer': true } );
ga('send', 'pageview');
</script>
<!-- Google Analytics end -->
		<div id="mobilebanner2" class="ad mobilebanner2"></div>
		<div class="accessibility-ad-header visually-hidden">
    <p>Advertisement</p>
</div>
<div id="SponLink" class="text-ad bottom-left-ad nocontent robots-nocontent"></div>

		<div id="Top5" class="ad top5-ad hidden nocontent robots-nocontent"></div>

					</div>
			<div class="search-overlay"></div>
		</main><!-- close main -->
						<footer id="page-footer" class="page-footer" role="contentinfo">
    <nav>
         <ul>
             <li>
                <a href="https://www.nytco.com" itemprop="copyrightNotice">
                    &copy; <span itemprop="copyrightYear">2017</span>
					<span itemprop="copyrightHolder provider sourceOrganization" itemscope
						itemtype="//schema.org/Organization"
						itemid="//www.nytimes.com">
						<span itemprop="name"> The New York Times Company</span>
						<meta itemprop="tickerSymbol" content="NYSE NYT"/>
					</span>
                </a>
            </li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/infoservdirectory.html">Contact Us</a></li>
            <li><a href="//www.nytco.com/careers/">Work With Us</a></li>
            <li><a href="//nytmediakit.com/">Advertise</a></li>
            <li><a href="https://www.nytimes.com/content/help/rights/privacy/policy/privacy-policy.html#pp">Your Ad Choices</a></li>
            <li><a href="https://www.nytimes.com/privacy">Privacy</a></li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/agree.html" itemprop="usageTerms">Terms of Service</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/content/help/rights/sale/terms-of-sale.html">Terms of Sale</a></li>
         </ul>
    </nav>
    <nav class="last-nav">
        <ul>
            <li><a href="//spiderbites.nytimes.com">Site Map</a></li>
            <li><a href="https://www.nytimes.com/membercenter/sitehelp.html">Help</a></li>
            <li><a href="https://myaccount.nytimes.com/membercenter/feedback.html">Site Feedback</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/subscriptions/Multiproduct/lp5558.html?campaignId=37WXW">Subscriptions</a></li>
        </ul>
    </nav>
</footer>		</div><!-- close shell -->
	<script>
require(['foundation/main'], function () {
    require(['blogs/main']);
    require(['jquery/nyt', 'foundation/views/page-manager'], function ($, pageManager) {
        if (window.location.search.indexOf('disable_tagx') > 0) {
            return;
        }
        $(document).ready(function () {
            require(['https://a1.nyt.com/analytics/json-kidd.min.js'], function () {
                pageManager.trackingFireEventQueue();
            });
        });
    });
});
</script>

	<div id="Inv1" class="ad inv1-ad hidden"></div>
<div id="Inv2" class="ad inv2-ad hidden"></div>
<div id="Inv3" class="ad inv3-ad hidden"></div>
<div id="ab1" class="ad ab1-ad hidden"></div>
<div id="ab2" class="ad ab2-ad hidden"></div>
<div id="ab3" class="ad ab3-ad hidden"></div>
<div id="prop1" class="ad prop1-ad hidden"></div>
<div id="prop2" class="ad prop2-ad hidden"></div>
<div id="Anchor" class="ad anchor-ad hidden"></div>
<div id="ADX_CLIENTSIDE" class="ad adx-clientside-ad hidden"></div>
		<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"b5bcf2eba4","applicationID":"5164608","transactionName":"YwFXZhRYVhAEVUZcX1pLYEAPFlkTFRtQWV9TFxtCDkk=","queueTime":0,"applicationTime":57,"ttGuid":"","agentToken":"","userAttributes":"","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
